LTR Pharma (ASX:LTP) Pretax Margin % : % (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. LTR Pharma's Pre-Tax Income for the six months ended in Jun. 2023 was A$-1.46 Mil. LTR Pharma's Revenue for the six months ended in Jun. 2023 was A$0.00 Mil. Therefore, LTR Pharma's pretax margin for the quarter that ended in Jun. 2023 was %.

The historical rank and industry rank for LTR Pharma's Pretax Margin % or its related term are showing as below:

ASX:LTP's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -154.275
* Ranked among companies with meaningful Pretax Margin % only.

LTR Pharma Pretax Margin % Historical Data

The historical data trend for LTR Pharma's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Pretax Margin % Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Pretax Margin %

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Pretax Margin %	-	-	-

Competitive Comparison of LTR Pharma's Pretax Margin %

For the Biotechnology subindustry, LTR Pharma's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LTR Pharma's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LTR Pharma's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where LTR Pharma's Pretax Margin % falls into.

LTR Pharma Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

LTR Pharma's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-1.455	/	0
	=	%

LTR Pharma's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-1.455	/	0
	=	%

LTR Pharma (ASX:LTP) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

LTR Pharma Pretax Margin % Related Terms

Thank you for viewing the detailed overview of LTR Pharma's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines